Back to search
FDAFDA · Food and drugs·Recall number D-0274-2024

Cefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by:Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01

Published February 7, 2024 · Recall initiated: January 3, 2024

Summary

FDA records drug Class II recall D-0274-2024, published February 7, 2024 and initiated January 3, 2024. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 4,608 Bottles; Lot: Lot #: F304833, Exp 06/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email if CEFIXIME has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CEFIXIME
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Nationwide in the USA
UPC
0368180423089
Lot
Lot #: F304833, Exp 06/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by:Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01 recalled?

Yes. FDA published recall D-0274-2024 on February 7, 2024. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CEFIXIME. UPC: 0368180423089.